In 2013, Hlaváč and colleagues published the results of their research on the search for new biomarkers of prognosis and/or predicting drug resistance among genes belonging to the ABC family in breast cancer patients (without division into molecular subtypes). This evidence concerns the gene ABCB6 and breast cancer.